Available online on 15.03.2026 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright   © 2026 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article   Review Article

Green Polymers for Human Welfare: Exploring Plant-Derived Natural Gums as Safe Polysaccharides in Sustainable Drug Delivery Systems

Tusara Kanta Behera *, Santosh Kumar Dash , Ram Shankar Naik , Roshan Kumar Pradhan , Pujarani Kalsai , Reshma Ranbir , Kshireswari Sahu , Priyanka Sharma 

Department of Pharmaceutics, The Pharmaceutical College, Barpali, Odisha, 768029

 

Graphical Abstract

1. Introduction

The growing emphasis on sustainability and patient safety has accelerated interest in natural polymers as alternatives to synthetic excipients in pharmaceutical formulations. Synthetic polymers, although widely used, may present issues related to toxicity, non-biodegradability, and environmental persistence. In contrast, natural polymers derived from plant sources are biodegradable, renewable, and generally recognized as safe, making them attractive candidates for drug delivery applications^1,2. Plant-derived natural gums are complex polysaccharides obtained from plant exudates (gum arabic, karaya), seeds (guar gum, locust bean gum), or fruits and barks. These materials have long been used in food and traditional medicine and are now increasingly explored as pharmaceutical excipients due to their functional versatility³. Their ability to hydrate, swell, and form viscous gels enables them to function as binders, disintegrants, matrix formers, stabilizers, and release-modifying agents in dosage forms⁴. Natural gums possess hydroxyl-rich polysaccharide backbones that allow hydrogen bonding and chemical derivatization, facilitating their application in controlled and targeted drug delivery systems⁵. Several studies have demonstrated the effectiveness of gums such as guar gum and pectin in colon-specific drug delivery due to their susceptibility to degradation by colonic microflora⁶. Similarly, xanthan and karaya gums have been used to develop hydrophilic matrices capable of sustaining drug release over extended periods⁷. This review aims to provide a comprehensive evaluation of plant-derived natural gums as green polymers for pharmaceutical use. It discusses their physicochemical properties, formulation advantages and challenges, chemical modification strategies, and applications in conventional and novel drug delivery systems. By synthesizing evidence from well-established scientific literature, the article underscores the potential of natural gums to support sustainable pharmaceutical development and improve human welfare.

2. Physicochemical Characteristics of Plant-Derived Natural Gums

Natural gums are high-molecular-weight polysaccharides composed mainly of monosaccharides such as galactose, mannose, arabinose, rhamnose, and glucuronic acid. Their molecular structure and composition significantly influence their functional performance in pharmaceutical formulations³.

2.1 Composition and Structure: In terms of composition and structure, most natural gums are composed of complex hetero polysaccharide chains with β-(1→4) or α-(1→6) glycosidic linkages. These structures are rich in hydroxyl groups, which enable extensive hydrogen bonding with water and other polymer chains, thereby promoting gel formation and effective film-coating behavior. Such molecular interactions are fundamental to their ability to form stable matrices for drug encapsulation and controlled release⁵.

2.2 Viscosity and Swelling Behaviour: Gums such as guar gum and xanthan gum readily hydrate in aqueous environments, forming highly viscous systems that are particularly advantageous for sustained- and controlled-release drug delivery. Their swelling behavior plays a critical role in regulating drug release kinetics, as it governs both matrix erosion and diffusion pathways, allowing for prolonged therapeutic action⁷.

2.3 Solubility and pH Sensitivity: pH sensitivity is also an important property of certain gums, including pectin and gum karaya, which exhibit solubility changes depending on the surrounding pH. This characteristic is especially valuable in the design of site-specific delivery systems, such as colon-targeted or gastric-retentive formulations, where drug release can be triggered selectively in specific regions of the gastrointestinal tract⁶.

2.4 Stability and Functional Properties: Natural gums exhibit multifunctional behavior in pharmaceutical formulations, acting as binders, emulsifiers, suspending agents, and film formers. Their stability is influenced by moisture content, microbial load, and processing conditions. Proper drying, purification, and storage are essential to maintain their physicochemical integrity and prevent microbial contamination⁸. Despite being thermally less stable than synthetic polymers, many natural gums retain adequate stability under standard pharmaceutical processing conditions, including wet granulation and compression⁹.

2.5 Modulation of Properties: Plant-derived gums possess diverse functional properties, including binding, emulsifying, and stabilizing abilities, which are essential for the formulation of tablets, emulsions, and suspensions. These multifunctional roles make natural gums versatile excipients in modern pharmaceutical dosage forms. The functional properties of plant gums can be modulated through polymer blending or chemical modification. Blending with polymers such as hydroxypropyl methylcellulose (HPMC), alginate, or chitosan improves mechanical strength, reproducibility, and drug release control¹⁰. These adaptable physicochemical characteristics make natural gums suitable candidates for a wide range of drug delivery systems.

3. Advantages and Limitations of Natural Gum Polysaccharides

3.1 Advantages

Biocompatibility and Safety: Their biocompatibility and biodegradability ensure that they are safe for human use and can be easily metabolized or eliminated from the body without causing adverse effects^1,3.

Biodegradability and Environmental Sustainability: These polymers undergo enzymatic degradation into harmless by-products, reducing environmental burden and supporting green pharmaceutical practices².

Renewable and Economical: Another important advantage is their renewability, as these polymers are derived from abundant plant sources, making them sustainable and environmentally responsible⁴.

Functional Versatility: Their functional diversity, including excellent swelling, binding, and film-forming properties, allows them to perform multiple roles such as matrix formers, stabilizers, and release modifiers in drug delivery systems⁷.

Mucoadhesive Properties: Furthermore, their mucoadhesive nature enhances drug residence time at mucosal surfaces, improving drug absorption and bioavailability in systems such as buccal, nasal, and ocular delivery¹¹.

3.2 Limitations

Batch-to-Batch Variability: One major concern is variability, since their physicochemical properties may differ depending on plant source, geographical location, and environmental conditions, leading to batch-to-batch inconsistency⁸.

Microbial Contamination: They are also prone to microbial contamination, which necessitates proper purification, drying, and sterilization to ensure safety and stability⁹.

Mechanical Weakness: In addition, many natural gums exhibit limited mechanical strength, making them less suitable for high-stress formulations unless modified through cross-linking or blending with other polymers¹⁰.

pH Sensitivity: Another limitation is their pH sensitivity, as some gums show variable performance under different gastrointestinal conditions, which can affect drug release profiles¹¹.

Storage Instability: Storage instability is a concern, since their hygroscopic nature makes them sensitive to moisture, potentially reducing shelf life and altering functional performance over time. 

Table 1: Tabular form of advantages and limitations

 

4. Applications in Conventional and Novel Drug Delivery Systems

4.1 Sustained-Release Matrix Systems: In sustained-release matrix tablets, gums such as guar gum and xanthan gum are commonly employed as matrix formers, where their high swelling and gel-forming capacity helps to regulate drug diffusion and matrix erosion, thereby providing prolonged and controlled release of drugs such as diclofenac sodium^7,13.

4.2 Mucoadhesive Drug Delivery Systems: In mucoadhesive drug delivery systems, natural gums including karaya and cashew gum exhibit strong adhesive interactions with mucosal surfaces. This property is particularly beneficial for buccal and vaginal formulations, as it enhances the residence time of the dosage form at the site of absorption, leading to improved drug bioavailability and therapeutic efficacy^11,14.

4.3 Gastro-Retentive and Floating Systems: In gastro-retentive or floating drug delivery systems, gums like karaya and tamarind gum are employed to increase buoyancy and gastric residence time. These properties are useful for drugs that are preferentially absorbed in the stomach or upper gastrointestinal tract, enabling sustained release and improved therapeutic outcomes¹⁵.

4.4 Colon-Targeted Drug Delivery: Finally, natural polysaccharides such as guar gum and pectin play a crucial role in colon-targeted drug delivery. These polymers resist digestion in the upper gastrointestinal tract but are selectively degraded by colonic microflora, allowing for site-specific drug release in the colon. This approach is particularly valuable for the treatment of local disorders such as ulcerative colitis and colorectal cancer^6,16.

4.5 Hydrogels, Films, and Particulate Systems: Natural gums are also widely used in the preparation of hydrogels and films. For instance, aloe gum and gum arabic can form bioadhesive and flexible hydrogel networks that are suitable for wound healing, transdermal patches, and other topical applications. These systems not only provide controlled drug release but also promote moisture retention and tissue regeneration^17,18.

4.6 Microspheres and Nanoparticles: In advanced delivery platforms, natural gums such as locust bean gum and okra mucilage have been successfully utilized in the fabrication of microspheres and nanoparticles. Their biocompatibility and ability to encapsulate both hydrophilic and hydrophobic drugs make them ideal candidates for microencapsulation and nanoparticulate drug delivery, offering enhanced stability, targeted delivery, and reduced side effects¹⁹.

5. Chemical Modification and Functionalization of Natural Gums 

Chemical modification and functionalization play a crucial role in enhancing the physicochemical and mechanical properties of natural gums, thereby expanding their applicability in advanced drug delivery systems.  Chemical derivatization enhances the physicochemical and mechanical properties of natural gums.

5.1 Carboxymethylation and Acetylation:

Furthermore, chemical treatments such as carboxymethylation and acetylation alter the polarity and hydrophilicity of gum molecules, leading to changes in solubility and swelling characteristics. These modifications make natural gums more pH-responsive and suitable for site-specific drug delivery, particularly in gastrointestinal applications²⁰.

5.2 Cross-Linking:

Through cross-linking, the polymer chains are interconnected to form a more stable three-dimensional network, which significantly improves mechanical strength, reduces rapid dissolution, and allows better control over drug release rates²¹.

5.3 Graft Copolymerization:

Another important strategy is graft copolymerization, in which functional monomers are chemically attached to the backbone of natural gums. This modification introduces new functional groups that can tailor solubility, improve responsiveness to environmental stimuli such as pH or temperature, and enhance compatibility with both hydrophilic and hydrophobic drugs. Such functionalization enables the design of smart delivery systems with controlled and targeted release behavior²². 

5.4 Blending:

In addition, polymer blending is widely used, where natural gums are combined with polymers like chitosan, HPMC, or alginate to improve bioadhesive properties, mechanical integrity, and overall formulation stability. Collectively, these chemical and physical modifications transform ordinary natural gums into versatile and high-performance biomaterials suitable for modern pharmaceutical and biomedical applications^23,24.

6. Smart and Site-Specific Drug Delivery Systems

Natural gums can be effectively transformed into smart polymers capable of responding to various physiological stimuli such as pH, temperature, and enzymatic activity, making them highly suitable for site-specific drug delivery systems. These stimulus-responsive properties allow natural gums to regulate drug release in a controlled manner depending on the biological environment, thereby improving therapeutic efficacy and minimizing systemic side effects²⁵. 

6.  Stomach-Targeted Systems: In stomach-targeted delivery systems, gums such as karaya and xanthan exhibit high swelling and gel-forming behavior in acidic conditions, which helps in prolonging gastric residence time. This characteristic is particularly useful for drugs that require extended exposure in the stomach or are primarily absorbed in the upper gastrointestinal tract. The swollen polymer matrix acts as a barrier to drug diffusion, ensuring sustained release and improved bioavailability²⁶. 
7. Intestinal Targeting: For intestinal targeting, chemically modified natural gums are designed to remain relatively stable in acidic gastric conditions but dissolve or swell in slightly alkaline environments. This enables controlled drug release in the small intestine, where optimal absorption occurs for many drugs. Such pH-responsive behavior enhances drug stability and prevents premature release in the stomach²⁷. 
8.  Colon-Specific Systems: In colon-specific drug delivery, polysaccharides such as guar gum, pectin, and locust bean gum play a vital role due to their susceptibility to degradation by colonic microflora. These polymers resist digestion in the upper gastrointestinal tract but undergo enzymatic breakdown in the colon, leading to localized and targeted drug release. This strategy is particularly beneficial in the treatment of diseases such as ulcerative colitis, Crohn’s disease, and colon cancer, where site-specific drug action can significantly improve therapeutic outcomes while reducing adverse effects²⁸. These smart systems enhance therapeutic efficiency while minimizing systemic side effects.

7. Recent Literature Overview and Comparative Insights

Recent studies consistently demonstrate that guar gum, xanthan gum, pectin, and gum karaya exhibit excellent swelling, mucoadhesion, and sustained-release properties. Chemically modified and blended formulations show improved reproducibility and mechanical strength compared with native gums. Comparative analyses suggest that natural gums can effectively replace synthetic polymers in many controlled-release applications without compromising performance^7,10,13.

8. Future Prospects and Challenges

Future research should focus on standardization, large-scale processing, and regulatory acceptance of natural gums. Integration with nanotechnology, polymer chemistry, and computational formulation design may further enhance their potential for application. Addressing challenges related to variability, microbial safety, and scalability will be essential for their widespread industrial adoption^2,21.

 

 

Table 2: Represents Research on Dosage Forms Using Natural Gums

 

 

9. Conclusion

Plant-based natural gums have emerged as flexible and sustainable biopolymers with great potential to change modern pharmaceutical formulations and drug delivery systems. Their natural properties include high viscosity, swelling capacity, film-forming abilities, and biocompatibility. These characteristics allow them to serve effectively as matrix formers, binders, and agents for modifying release in both traditional and newer dosage forms. Compared to synthetic polymers, natural gums offer extra benefits such as renewability, biodegradability, low toxicity, and cost-effectiveness. These features make them suitable for the growing global demand for eco-friendly pharmaceutical materials. This review highlights that while there are some drawbacks, such as variability between batches and sensitivity to microbial contamination, these issues can be largely addressed through purification methods, chemical changes, and polymer blending strategies. The development of smart, responsive gum-based systems further improves their application in targeted and extended drug delivery, potentially leading to better therapeutic outcomes and enhanced patient adherence.  In conclusion, plant-derived gums present a promising option as excipients that can promote sustainable innovation in pharmaceuticals. Ongoing research into their structural improvement, functional changes, and large-scale production will be vital to unlock their full potential. With the rising emphasis on eco-friendly technologies and patient-centered formulations, natural gums are poised to make a significant impact on the future of drug delivery and support the sustainability of global healthcare.

Acknowledgement: We acknowledge the support of The Pharmaceutical College, Barpali, for providing access to library and research facilities for this review. We also grateful to colleagues and peers who provided valuable suggestions and constructive feedback during the preparation of this manuscript.

Author’s Contribution: All authors contributed equally to the conception and design of the review. Literature search, data collection, analysis, and manuscript drafting were performed by the authors. All authors critically revised the manuscript, approved the final version, and agree to be accountable for all aspects of the work

Funding Source: This review did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest: The authors declare that there is no conflict of interest regarding the publication of this review article.

Ethical Approval: This article is a review based on previously published studies; therefore, ethical approval was not required.

References

1. Kumar S, Gupta SK. Natural polymers, gums and mucilages as excipients in drug delivery. Polim Med. 2012;42(3-4):191-197.

2. Thakur VK, Thakur MK. Processing and characterization of natural cellulose fibers/thermoset polymer composites. Carbohydr Polym. 2014;109:102-117. https://doi.org/10.1016/j.carbpol.2014.03.039 PMid:24815407

3. Prajapati VD et al. Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydr Polym. 2013;92(2):1685-1699. https://doi.org/10.1016/j.carbpol.2012.11.021 PMid:23399207

4. Patel VR, Amiji MM. Pharmaceutical excipients derived from natural sources. Pharm Technol. 2015;39:42-50.

5. Singh B, Sharma N. Modification of natural gums: methods, properties and applications. Carbohydr Polym. 2017;177:37-48. https://doi.org/10.1016/j.carbpol.2017.08.060 PMid:28927630

6. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;224(1-2):19-38.https://doi.org/10.1016/S0378-5173(01)00720-7 PMid:11472812

7. Reddy KR et al. Once-daily sustained-release matrix tablets of nicorandil. AAPS PharmSciTech. 2003;4(4):E61. https://doi.org/10.1208/pt040461 PMid:15198556 PMCid:PMC2750654

8. Rowe RC et al. Handbook of Pharmaceutical Excipients. 6th ed. 2009.

9. Kulkarni GT et al. Binding properties of mucilages. Indian J Pharm Sci. 2002;64(5):482-486.

10. Nokhodchi A et al. Oral controlled-release matrix tablets. Biomed Res Int. 2014;2014:1-16. 

11. Andrews GP et al. Mucoadhesive polymeric platforms. Eur J Pharm Biopharm. 2009;71(3):505-518. https://doi.org/10.1016/j.ejpb.2008.09.004 PMid:18835441

12. Builders PF, Anwunobi PA. Mucilage in drug delivery. J Pharm Allied Sci. 2012;9(1):1-17.

13. Colombo P et al. Swelling and release mechanisms. J Control Release. 1996;39(2-3):231-237. https://doi.org/10.1016/0168-3659(95)00158-1

14. Smart JD. Mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556-1568. https://doi.org/10.1016/j.addr.2005.07.001 PMid:16198441

15. Deshpande AA et al. Gastric retention system. Pharm Res. 1997;14(6):815-819. https://doi.org/10.1023/A:1012171010492 PMid:9210203

16. Chourasia MK, Jain SK. Colon targeted systems. J Pharm Pharm Sci. 2003;6(1):33-66.

17. George M, Abraham TE. Alginate & chitosan. J Control Release. 2006;114(1):1-14. https://doi.org/10.1016/j.jconrel.2006.04.017 PMid:16828914

18. McClements DJ. Encapsulation systems. Adv Colloid Interface Sci. 2015;219:27-53. https://doi.org/10.1016/j.cis.2015.02.002 PMid:25747522

19. Koyyada A, Orsu P. Natural gum polysaccharides. J Drug Deliv Sci Technol. 2021;63:102431. https://doi.org/10.1016/j.jddst.2021.102431

20. Badwaik HR et al. Carboxymethylation of polysaccharides. Int J Biol Macromol. 2015;79:939-950. https://doi.org/10.1016/j.ijbiomac.2015.06.017 PMid:26092169

21. Peppas NA, Khare AR. Hydrogels. Adv Drug Deliv Rev. 1993;11(1-2):1-35. https://doi.org/10.1016/0169-409X(93)90025-Y

22. Pushpamalar J et al. Biodegradable polysaccharides. ChemPlusChem. 2016;81(6):504-514. https://doi.org/10.1002/cplu.201600112 PMid:31968918

23. Kruk K, Winnicka K. Alginate platforms. Mar Drugs. 2023;21(1):11. https://doi.org/10.3390/md21010011 PMid:36662184 PMCid:PMC9861938

24. Cirillo G et al. Alginate-graphene hydrogels. Molecules. 2021;26(5):1355. https://doi.org/10.3390/molecules26051355 PMid:33802608 PMCid:PMC7961670

25. Madineh H et al. Stimuli-responsive systems. Int J Biol Macromol. 2025;142648. https://doi.org/10.1016/j.ijbiomac.2025.142648 PMid:40174846

26. Munday DL, Cox PJ. Xanthan & karaya matrices. Int J Pharm. 2000;203(1-2):179-192. https://doi.org/10.1016/S0378-5173(00)00471-3 PMid:11000537

27. Vegad U et al. pH-responsive hydrogels. Front Bioeng Biotechnol. 2023;11:1270364. https://doi.org/10.3389/fbioe.2023.1270364 PMid:37781530 PMCid:PMC10540072

28. Sinha VR, Kumria R. Microbially triggered delivery. Eur J Pharm Sci. 2003;18(1):3-18. https://doi.org/10.1016/S0928-0987(02)00242-7 PMid:12554075

29. Rajamma AJ et al. Gastroretentive system. DARU J Pharm Sci. 2012;20:58. https://doi.org/10.1186/2008-2231-20-58 PMid:23352292 PMCid:PMC3556007

30. Varshosaz J et al. Metoprolol tablets. Drug Dev Ind Pharm. 2006;32(4):461-467. https://doi.org/10.1080/03639040500405866 

31. Üner M, Altinkurt T. Honey locust gum. Il Farmaco. 2004;59(7):567-573. https://doi.org/10.1016/j.farmac.2004.04.005 PMid:15231434

32. Sivakumar T, Gopi D. Tramadol SR tablets. Drug Dev Ind Pharm. 2006;32(4):461-467. https://doi.org/10.1080/03639040500405866 

33. Gande S, Rao YM. Floating baclofen tablets. DARU J Pharm Sci. 2011;19(3):202-209. https://doi.org/10.1186/1560-8115-19-202 

34. Hamman HH et al. Natural gums as excipients. Curr Pharm Des. 2015;21(33):4835-4848.  https://doi.org/10.2174/1381612821666150820100524 PMid:26290212

35. Dash SK et al. Pulsatile delivery system. Int J Pharm Sci Res. 2020;11(7):3229-3242. https://doi.org/10.13040/IJPSR.0975-8232.11(7).3229-42

36. Malviya R et al. Gum modification. Recent Pat Drug Deliv Formul. 2020;14(3):214-222. https://doi.org/10.2174/1872211314666201204160641 PMid:33280600